India  
 
NewsR.in

Novavax Selected To Receive $1.6B In Federal Funding For COVID-19 Vaccine Clinical Trial

Video Credit: WJZ Baltimore - Duration: 00:48s - Published
Novavax Selected To Receive $1.6B In Federal Funding For COVID-19 Vaccine Clinical Trial

Novavax Selected To Receive $1.6B In Federal Funding For COVID-19 Vaccine Clinical Trial

A Maryland biotechnology company will receive $1.6 billion in federal funding to help them to continue to develop and hold a clinical trial for a coronavirus vaccine this year.


You Might Like


Related videos from verified sources

First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US [Video]

First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US

First Phase 3 Coronavirus Vaccine Candidate Begins Testing in US The experimental vaccine, developed by Moderna and the National Institute of Allergy and Infectious Diseases, began Phase 3 trials on..

Credit: Wibbitz Top Stories     Duration: 01:05Published
Help wanted! Clinical trials launched to test COVID-19 vaccines [Video]

Help wanted! Clinical trials launched to test COVID-19 vaccines

Federal officials have set up an online registry to enroll people from different age groups, races and health backgrounds to test potential vaccines.

Credit: WCVB     Duration: 01:39Published